BACKGROUND: Nicotine is known to produce pain-inhibitory effects. Here, we examine whether there is a relation between tobacco smoking and analgesic drug use (ADU). METHODS: A probability sample of the German national population aged 18-79 with 7124 participants (participation rate: 61.4%) was used. All individuals underwent a health examination and ADU was assessed as part of an interview conducted by a study physician. RESULTS: Current and former smokers had higher odds for ADU than never smokers. Current heavy smokers (>20 cigarettes per day) had an odds ratio (OR) of 1.8 (95% confidence interval, CI, 1.4-2.3) for ADU three times per month or less and an OR of 3.1 (CI 2.0-4.8) for ADU once a week to daily, with never smokers as the reference group. Former heavy smokers had an OR of 2.0 (CI 1.3-3.2) for ADU once a week to daily compared to never smokers. CONCLUSION: The findings suggest that current and former smokers, particularly current and former heavy smokers, are more likely to use analgesic drugs than never smokers.
BACKGROUND:Nicotine is known to produce pain-inhibitory effects. Here, we examine whether there is a relation between tobacco smoking and analgesic drug use (ADU). METHODS: A probability sample of the German national population aged 18-79 with 7124 participants (participation rate: 61.4%) was used. All individuals underwent a health examination and ADU was assessed as part of an interview conducted by a study physician. RESULTS: Current and former smokers had higher odds for ADU than never smokers. Current heavy smokers (>20 cigarettes per day) had an odds ratio (OR) of 1.8 (95% confidence interval, CI, 1.4-2.3) for ADU three times per month or less and an OR of 3.1 (CI 2.0-4.8) for ADU once a week to daily, with never smokers as the reference group. Former heavy smokers had an OR of 2.0 (CI 1.3-3.2) for ADU once a week to daily compared to never smokers. CONCLUSION: The findings suggest that current and former smokers, particularly current and former heavy smokers, are more likely to use analgesic drugs than never smokers.
Authors: Emily L Zale; Michelle L Dorfman; W Michael Hooten; David O Warner; Michael J Zvolensky; Joseph W Ditre Journal: Nicotine Tob Res Date: 2014-10-25 Impact factor: 4.244
Authors: Alexander L Patterson; Susan Gritzner; Michael P Resnick; Steven K Dobscha; Dennis C Turk; Benjamin J Morasco Journal: J Pain Date: 2012-02-09 Impact factor: 5.820
Authors: Marina Unrod; Ronald J Gironda; Michael E Clark; Kristi E White; Vani N Simmons; Steven K Sutton; Thomas H Brandon Journal: Pain Med Date: 2014-02-15 Impact factor: 3.750
Authors: Jean L Richardson; Bonnie Heikes; Roksanna Karim; Kathleen Weber; Kathryn Anastos; Mary Young Journal: AIDS Patient Care STDS Date: 2009-07 Impact factor: 5.078
Authors: Kimberly T Green; Sarah M Wilson; Paul A Dennis; Jennifer J Runnals; Rebecca A Williams; Lori A Bastian; Jean C Beckham; Eric A Dedert; Harold S Kudler; Kristy Straits-Tröster; Jennifer M Gierisch; Patrick S Calhoun Journal: Pain Med Date: 2017-09-01 Impact factor: 3.750